Prof. Klaus Olek

Prof. Klaus Olek

Prof. Olek senior started his career as one of the very first Human Geneticists in Germany, as early as the late 1970ies, to fully embrace Molecular Biology as the coming center-piece of all genetic research. Much of his research was groundbreaking at the time, not least his contribution to the discovery of the gene responsible for Cystic Fibrosis.
Prof. Olek left academia in 1990 to become one of Germany’s first entrepreneurs in Molecular Human Genetics with his company “Institut für molekulare Diagnostik GmbH”. Later, after a successful exit from that company, he started to specialize in animal genetics with his new company, “Biopsytec GmbH”, an enterprise which he founded with Dr. Olek junior and ran together with Mr. Heuermann. After Biopsytec was sold to the global market leader in the field, the company Certagen was split out and became the German market leader in genetic testing for domestic animal breeding, most notably being responsible for more than half of all genetic pedigree certification in German-bred horses. At the same time, he founded Sanobis GmbH, Germany’s leading company in the application of Next Generation Sequencing methods to the differential diagnostics of breast cancer and a number of hereditary diseases. There, he still serves as a managing director, but dedicates the majority of his time to LfA, founded in 2010, which today is the market leader in genetics for rare and protected species for which no established genetic marker systems exist. Consequently, his network in the world of zoos and breeders of protected species is uniquely broad.